Search hospitals > Florida > Fort Lauderdale
Broward Health Medical Center
Claim this profileFort Lauderdale, Florida 33316
Global Leader in Breast Cancer
Global Leader in Cancer
Conducts research for Leukemia
Conducts research for Lymphoma
Conducts research for Acute Lymphoblastic Leukemia
244 reported clinical trials
8 medical researchers
Summary
Broward Health Medical Center is a medical facility located in Fort Lauderdale, Florida. This center is recognized for care of Breast Cancer, Cancer, Leukemia, Lymphoma, Acute Lymphoblastic Leukemia and other specialties. Broward Health Medical Center is involved with conducting 244 clinical trials across 404 conditions. There are 8 research doctors associated with this hospital, such as Hector M. Rodriguez-Cortes, Brian Slomovitz, Shannon B. Keating, and Mehmet F. Hepgur.Area of expertise
1Breast Cancer
Global LeaderStage IV
HER2 negative
ER positive
2Cancer
Global LeaderStage I
Stage IV
Stage II
Top PIs
Hector M. Rodriguez-CortesBroward Health Medical Center8 years of reported clinical research
Expert in Cancer
Studies Neuroblastoma
32 reported clinical trials
74 drugs studied
Brian SlomovitzMount Sinai Comprehensive Cancer Center3 years of reported clinical research
Studies Endometrial Cancer
Studies Ovarian Cancer
16 reported clinical trials
30 drugs studied
Shannon B. KeatingBroward Health Medical Center2 years of reported clinical research
Studies Breast Cancer
Studies Breast cancer
6 reported clinical trials
20 drugs studied
Mehmet F. HepgurBroward Health Medical Center7 years of reported clinical research
Studies Breast Cancer
Studies Breast cancer
5 reported clinical trials
26 drugs studied
Clinical Trials running at Broward Health Medical Center
Ovarian Cancer
Breast Cancer
Breast cancer
Cancer
Cervical Cancer
Lung Cancer
Uterine Cancer
Prostate Cancer
Testicular cancer
Wilms Tumor
Mirvetuximab + Bevacizumab
for Ovarian Cancer
GLORIOSA is a Phase 3 multicenter, open label study designed to evaluate the safety and efficacy of mirvetuximab Soravtansine + Bevacizumab as maintenance therapy in participants with platinum-sensitive ovarian, primary peritoneal or fallopian tube cancers with high folate receptor-alpha (FRα) expression.
Recruiting2 awards Phase 3
Trastuzumab Deruxtecan + Bevacizumab
for Ovarian Cancer
This clinical trial is designed to evaluate the efficacy and safety of T-DXd in combination with bevacizumab versus bevacizumab monotherapy as first-line maintenance therapy, in participants with human epidermal growth factor 2 (HER2)-expressing (immunohistochemistry \[IHC\] 3+/2+/1+) advanced high-grade epithelial ovarian cancer.
Recruiting2 awards Phase 35 criteria
Olaparib +/- Bevacizumab
for Ovarian Cancer
This phase III trial compares the effect of olaparib for one year versus two years, with or without bevacizumab, for the treatment of BRCA 1/2 mutated or homologous recombination deficient stage III or IV ovarian cancer. Olaparib is a polyadenosine 5'-diphosphoribose polymerase (PARP) enzyme inhibitor and may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Bevacizumab is in a class of medications called antiangiogenic agents. It works by stopping the formation of blood vessels that bring oxygen and nutrients to tumor. This may slow the growth and spread of tumor. Giving olaparib for one year with or without bevacizumab may be effective in treating patients with BRCA 1/2 mutated or homologous recombination deficient stage III or IV ovarian cancer, when compared to two years of olaparib.
Recruiting2 awards Phase 34 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Broward Health Medical Center?
Broward Health Medical Center is a medical facility located in Fort Lauderdale, Florida. This center is recognized for care of Breast Cancer, Cancer, Leukemia, Lymphoma, Acute Lymphoblastic Leukemia and other specialties. Broward Health Medical Center is involved with conducting 244 clinical trials across 404 conditions. There are 8 research doctors associated with this hospital, such as Hector M. Rodriguez-Cortes, Brian Slomovitz, Shannon B. Keating, and Mehmet F. Hepgur.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.